Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-25-013536
Filing Date
2025-04-29
Accepted
2025-04-29 16:17:28
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A acrx20241231_10ka.htm   iXBRL 10-K/A 695023
2 EXHIBIT 31.1 ex_807347.htm EX-31.1 4012
3 EXHIBIT 31.2 ex_807348.htm EX-31.2 4058
  Complete submission text file 0001437749-25-013536.txt   1021483

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tlph-20241231.xsd EX-101.SCH 5409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20241231_def.xml EX-101.DEF 16699
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20241231_lab.xml EX-101.LAB 35604
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20241231_pre.xml EX-101.PRE 21158
20 EXTRACTED XBRL INSTANCE DOCUMENT acrx20241231_10ka_htm.xml XML 12602
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35068 | Film No.: 25887879
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)